What You Should Know:
- A new analysis from Vizient® reveals the staggering financial impact of drug shortages on U.S. hospitals, with labor costs for managing these disruptions more than doubling since 2019.
- The survey, "Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions," found that in 2023, hospitals spent roughly 20 million hours managing drug shortages, translating to nearly $900 million annually in labor costs.
The Hidden Costs Go Far Beyond
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
PwC: Health Services M&A Remains Durable Despite Headwinds
What You Should Know:
- Health services M&A activity has demonstrated remarkable durability, weathering a complicated macroeconomic and political environment to remain well ahead of pre-COVID levels, according to PwC’s US Deals 2025 Mid-Year Outlook for both Health Services and Pharmaceutical and Life Sciences.
- Through May 15, 2025, the market saw 445 announced transactions, bringing the last-twelve-month (LTM) total to 1,265 deals with a disclosed value of approximately
Read More
European Digital Health Startups Face ‘Existential Risk’ Amid Funding Pullback and ROI Demands, New Report Finds
What You Should Know:
- A new report from Black Book Research reveals significant headwinds facing the European digital health sector, with a survey of 54 early-stage startups highlighting investor pullback, cross-border scalability challenges, and increasing demands from health systems for evidence-based ROI.
- The findings paint a picture of a market in a "precarious holding pattern," where many innovative companies are struggling to survive.
Pandemic-Era Winners Now
Read More
The Overlooked Connection Between GLP-1s, Obesity, and Eating Disorders
The false belief that people with obesity do not have eating disorders is one of the most harmful misconceptions in obesity care. In reality, individuals with obesity are at a high risk for eating disorders.
The intersection of obesity, mental health, and disordered eating is complex. As GLP-1 receptor agonists (like semaglutide and tirzepatide) become more widely used for weight management, the risk of exacerbating eating disorders must be addressed. Obesity is not just a metabolic
Read More
Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients via RPM
What You Should Know:
- Quest Health Solutions, a national leader in diabetes care, today announced compelling results from its Remote Patient Monitoring (RPM) program, developed in partnership with the digital health company Rimidi. In just two months, the Quest Health RPM Services—powered by Rimidi's EHR-integrated platform—led to an 11% improvement in average blood glucose readings among participating patients.
- The collaboration highlights the power of combining
Read More
Cohere Health Launches AI Tool to Cut Medical Review Time by 50%
What You Should Know:
- Cohere Health®, the leader in clinical intelligence solutions for health plans and risk-bearing providers, today announced the launch of Review Assist, a breakthrough agentic AI solution that improves medical necessity review efficiency by up to 50% with over 99% precision.
- Designed to work seamlessly with health plans' existing utilization management (UM) workflows and technology stacks, Review Assist reduces review time, eases administrative burden, and improves
Read More
Tombot Secures $6.1M to Bring Lifelike Robotic Puppy to Seniors with Dementia
What You Should Know:
- Tombot, a leading innovator in robotic companion technology, has successfully closed an oversubscribed $6.1 million Series A funding round to support its groundbreaking line of health and senior care products.
- The company gained national attention at CES 2025 with its lifelike robotic puppy, Jennie.
Tombot Raises $6.1M Series A to Revolutionize Senior and Mental Health Care with Robotic Companion Animals
Tombot is strategically positioned at the
Read More
Glytec Secures $36M to Advance AI-Powered Diabetes Care and Inpatient Glycemic Management
What You Should Know:
- Glytec, a provider of an AI-powered technology platform for diabetes and related conditions, secures a $36M growth investment led by Savitr Capital and Hayfin Capital Management.
- The funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, and accelerate the development of innovative new technologies. The investment comes as healthcare systems face increasing pressure to improve inpatient
Read More
Artera Launches Real-World Registry to Track AI’s Impact in Cancer Care
What You Should Know:
- Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the launch of its DIRECT-AI registry study. This new study will assess how the ArteraAI Prostate Test influences treatment decision-making between clinicians and patients with localized prostate cancer.
- The study will also monitor participants to evaluate their long-term cancer outcomes, reinforcing Artera's commitment to advancing
Read More
Omada Health Data Shows Companion Program Significantly Boosts GLP-1 Medication Persistence
What You Should Know:
- Omada Health, the virtual between-visit healthcare provider released new data demonstrating that its GLP-1 companion program significantly improves persistence rates for GLP-1 medications.
- The analysis found that members in Omada's program achieved weight loss results similar to those seen in controlled research settings, underscoring the importance of comprehensive support for individuals on these transformative medications.
- The findings provide
Read More
